Atlas Trials

The Relationship of Defeverscence and Itraconazole Plasma Level Study in Immunocompromised Participants

Clinical trial NCT01021683 · COMPLETED

Trial details

NCT number
NCT01021683
Sponsor
Janssen Korea, Ltd., Korea
Status
COMPLETED
Study type
OBSERVATIONAL
Hematologic NeoplasmsNeutropeniaFever
Start date
2009-07-01
Primary completion
2010-07-01
Enrollment
203

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.